1-15 of 97
Playing the Long Game: Improving Durable Control in IBD
CME/CEPlaying the Long Game: Improving Durable Control in IBD
Anita Afzali, MD, MPH, MHCM, FACG, AGAF
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
CME/CEIBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
MinuteCE®Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Navigating IBD Guidelines: What Clinicians Need to Know Now
MinuteCE®Navigating IBD Guidelines: What Clinicians Need to Know Now
Michael Dolinger, MD, MBA
David T. Rubin, MD
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
MinuteCE®Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Michael Dolinger, MD, MBA
David T. Rubin, MD
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
- advertisement
David T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
MinuteCE®Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Florence Odufalu, MD
David T. Rubin, MD
The Evolving Role of Small Molecules in IBD Care
MinuteCE®The Evolving Role of Small Molecules in IBD Care
Florence Odufalu, MD
David T. Rubin, MD
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
MinuteCE®Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Ugo Iroku, MD, MHS
Michael Dolinger, MD, MBA
Translating Advances into Practice: Lessons from Today’s IBD Landscape
MinuteCE®Translating Advances into Practice: Lessons from Today’s IBD Landscape
Ugo Iroku, MD, MHS
David T. Rubin, MD
- advertisement
The Future of Biologic Treatment in IBD: What’s on the Horizon
MinuteCE®The Future of Biologic Treatment in IBD: What’s on the Horizon
Michael Dolinger, MD, MBA
David T. Rubin, MD
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
MinuteCE®Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Setting the Stage: Why Rethinking IBD Care Matters Now
MinuteCE®Setting the Stage: Why Rethinking IBD Care Matters Now
Florence Odufalu, MD
Ugo Iroku, MD, MHS